Crystalens® is:
- The first and only FDA-approved accommodating intraocular lens
- The only FDA approved intraocular lens that uses the natural focusing ability of the eye
- The only FDA approved presbyopia correcting IOL for cataract patients that provides a single focal point throughout a continuous range of vision
Few patients with Crystalens have experienced problems with glare, halos and night vision. crystalens focuses only one image to the back of the eye, unlike a multifocal lens that projects multiple images, requiring your brain to “adjust” to the differences.
The effectiveness of Crystalens® was proven in clinical trials:
- Significantly more patients implanted with a Crystalens (88.4%) could see better at all distances then patients implanted with a standard IOL (35.9%).
- Most patients have continued to report excellent vision 7 years after implantation with Crystalens. More than 95,000 crystalens implants have been implanted worldwide, and that number is growing daily.
Crystalens accommodates like the natural lens. After implantation of Crystalens, most patients will see brighter and clearer from distance, intermediate to near like they did when they were younger.
In clinical trials, more than 98% of patients who received Crystalens implants in both eyes had uncorrected visual acuity of 20/30 or better at distance without glasses, and could read 6 point type on a medicine bottle; and 92% had distance visual acuity of 20/25 or better. All enjoyed good intermediate vision one year after implantation, and 93.8% of patients surveyed said they could perform most daily activities without glasses.